Ayurvedic treatment for thyroid

A randomized controlled trial on shivagutika in the management of primary hypothyroidism

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012296

Enrollment

Registered

2018-03-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Primary Hypothyroidism

Interventions

Intervention1: Shiva gutika: Tablet of Shiva gutika weighing approx 2gm. each will be prepared in Parul Ayurvedic Pharmacy as per SOP-gutika Kalpana.The identification of ingredients will be done pha

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are diagnosed as primary hypothyroidism

Exclusion criteria

Exclusion criteria: 1.Patients suffering from systemic diseases like cardiac problems, diabetes, carcinomas etc. 2.Patients suffering from congenital hypothyroidism and secondary hypothyroidism. 3.Pregnant women,patients with hyperthyroidism will be excluded

Design outcomes

Primary

Measure	Time frame
Quality of Life will be assessed in every 1 month during the treatment and after one month of completion of treatment. Thyroid profile will be assessed after the completion of treatment.Timepoint: 12 weeks	—

Secondary

Measure	Time frame
Normal TSH valuesTimepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDr Kshama Gupta

Parul Institute of Ayurved

drkshamagupta@gmail.com7567222309

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026